INDOCID Suppositories Ref.[6928] Active ingredients: Indometacin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland

Product name and form

Indocid Suppositories 100 mg.

Pharmaceutical Form

Indocid is available in polyethylene glycol suppositories.

Qualitative and quantitative composition

Indocid Suppositories contains 100 mg of indometacin.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Indometacin

Indometacin has anti-inflammatory, antipyretic, and analgesic effects, it is an inhibitor of prostaglandin synthetase.
List of Excipients

Butylhydroxyanisole
Butylhydroxytoluene
Ethylenediamine-tetracrotic acid
Glycerol
Polyethylene glycol 8000
Macrogol 4000
Purified water

Pack sizes and marketing

10 capsules packed in polyvinylchloride (pvc) blister, laminate strip packaging.

Marketing authorization holder

Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland

Marketing authorization dates and numbers

PL 39699/0015

Date of first authorisation: 13 October 1981

Drugs

Drug Countries
INDOCID Austria, Australia, Brazil, Estonia, France, Hong Kong, Mexico, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈